LIGAND PHARMACEUTICALS INCORPORATED: cash_and_equivalents
| Value | {"amount": 108238000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2015-06-30) |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:34.912701+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/83ccc44c-939b-4f42-a980-5c747a943fee
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000886163-15-000085Retrieved: 2026-08-19T08:53:34.912701+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/cash-and-equivalents/2015-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/83ccc44c-939b-4f42-a980-5c747a943fee
History
- no predecessors — first report